Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.

Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.

Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...

The Danish government plans to significantly toughen penalties for opioid-related crimes, increasing sentences by more than 400 percent. Justice Minister Peter Hummelgaard announced the proposal today ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 10 includes Advanced Micro Devices, Novo Nordisk ...

Danish pharmaceutical company Novo Nordisk has expanded its presence in Thailand by reopening its renovated and enlarged ...

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...

A new agreement in Denmark’s industrial sector was found between Dansk Industri and CO-industry, a federation of labor unions representing employees in the industrial sector. These agreements will ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...

Forecast issued at 5:00 am WST on Saturday 8 February 2025. Partly cloudy. Slight chance of a shower. The chance of a thunderstorm in the morning and afternoon. Winds east to northeasterly 25 to 35 km ...